These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25003233)

  • 1. mNos2 deletion and human NOS2 replacement in Alzheimer disease models.
    Colton CA; Wilson JG; Everhart A; Wilcock DM; Puoliväli J; Heikkinen T; Oksman J; Jääskeläinen O; Lehtimäki K; Laitinen T; Vartiainen N; Vitek MP
    J Neuropathol Exp Neurol; 2014 Aug; 73(8):752-69. PubMed ID: 25003233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.
    Wilcock DM; Gharkholonarehe N; Van Nostrand WE; Davis J; Vitek MP; Colton CA
    J Neurosci; 2009 Jun; 29(25):7957-65. PubMed ID: 19553436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
    LeVault KR; Tischkau SA; Brewer GJ
    J Alzheimers Dis; 2016; 49(2):301-16. PubMed ID: 26484899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of human and mouse differences in NOS2 gene expression on the brain's redox and immune environment.
    Hoos MD; Vitek MP; Ridnour LA; Wilson J; Jansen M; Everhart A; Wink DA; Colton CA
    Mol Neurodegener; 2014 Nov; 9():50. PubMed ID: 25403885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.
    Wilcock DM; Lewis MR; Van Nostrand WE; Davis J; Previti ML; Gharkholonarehe N; Vitek MP; Colton CA
    J Neurosci; 2008 Feb; 28(7):1537-45. PubMed ID: 18272675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.
    Kan MJ; Lee JE; Wilson JG; Everhart AL; Brown CM; Hoofnagle AN; Jansen M; Vitek MP; Gunn MD; Colton CA
    J Neurosci; 2015 Apr; 35(15):5969-82. PubMed ID: 25878270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.
    Colton CA; Vitek MP; Wink DA; Xu Q; Cantillana V; Previti ML; Van Nostrand WE; Weinberg JB; Dawson H
    Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12867-72. PubMed ID: 16908860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.
    Hoos MD; Richardson BM; Foster MW; Everhart A; Thompson JW; Moseley MA; Colton CA
    J Proteome Res; 2013 Oct; 12(10):4462-77. PubMed ID: 24006891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.
    Colton CA; Wilcock DM; Wink DA; Davis J; Van Nostrand WE; Vitek MP
    J Alzheimers Dis; 2008 Dec; 15(4):571-87. PubMed ID: 19096157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice.
    Dunkelmann T; Schemmert S; Honold D; Teichmann K; Butzküven E; Demuth HU; Shah NJ; Langen KJ; Kutzsche J; Willbold D; Willuweit A
    J Alzheimers Dis; 2018; 63(1):115-130. PubMed ID: 29578479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype.
    Sudduth TL; Wilson JG; Everhart A; Colton CA; Wilcock DM
    PLoS One; 2012; 7(2):e31993. PubMed ID: 22347510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.
    Chu J; Giannopoulos PF; Ceballos-Diaz C; Golde TE; Praticò D
    Ann Neurol; 2012 Sep; 72(3):442-54. PubMed ID: 23034916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
    Wu PJ; Hung YF; Liu HY; Hsueh YP
    Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.